Wells Fargo & Company Arcutis Biotherapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 35,773 shares of ARQT stock, worth $331,257. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,773

Previous 36,565 2.17%

Holding current value

$331,257

Previous $340,000 2.35%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$8.32 - $11.0 $6,589 - $8,712	-792 Reduced 2.17%	35,773 $332,000
Q2 2024 Aug 13, 2024	BUY	$7.24 - $12.53 $63,762 - $110,351	8,807 Added 31.73%	36,565 $340,000
Q1 2024 May 10, 2024	BUY	$3.25 - $11.77 $19,968 - $72,314	6,144 Added 28.43%	27,758 $275,000
Q4 2023 Feb 09, 2024	SELL	$1.84 - $4.82 $119,901 - $314,090	-65,164 Reduced 75.09%	21,614 $69,000
Q3 2023 Nov 13, 2023	SELL	$5.31 - $10.98 $106,051 - $219,292	-19,972 Reduced 18.71%	86,778 $460,000
Q2 2023 Aug 15, 2023	BUY	$7.51 - $15.0 $331,303 - $661,725	44,115 Added 70.43%	106,750 $1.02 Million
Q1 2023 May 12, 2023	BUY	$10.23 - $17.14 $605,564 - $1.01 Million	59,195 Added 1720.78%	62,635 $688,000
Q4 2022 Feb 13, 2023	SELL	$13.96 - $20.4 $5,891 - $8,608	-422 Reduced 10.93%	3,440 $50,000
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $3,498 - $5,282	196 Added 5.35%	3,862 $73,000
Q2 2022 Aug 12, 2022	SELL	$16.33 - $22.2 $2.21 Million - $3 Million	-135,069 Reduced 97.36%	3,666 $78,000
Q1 2022 May 16, 2022	SELL	$14.38 - $22.79 $40,652 - $64,427	-2,827 Reduced 2.0%	138,735 $2.67 Million
Q4 2021 Feb 14, 2022	SELL	$14.98 - $25.5 $9.46 Million - $16.1 Million	-631,652 Reduced 81.69%	141,562 $2.94 Million
Q3 2021 Nov 15, 2021	SELL	$19.28 - $27.1 $2.41 Million - $3.38 Million	-124,758 Reduced 13.89%	773,214 $18.5 Million
Q2 2021 Aug 16, 2021	BUY	$24.42 - $34.75 $522,294 - $743,233	21,388 Added 2.44%	897,972 $24.5 Million
Q1 2021 May 13, 2021	BUY	$24.47 - $36.98 $5.7 Million - $8.62 Million	233,128 Added 36.23%	876,584 $25.4 Million
Q4 2020 Feb 09, 2021	BUY	$17.82 - $31.73 $1.55 Million - $2.76 Million	87,093 Added 15.65%	643,456 $18.1 Million
Q3 2020 Nov 05, 2020	BUY	$23.44 - $32.28 $685,291 - $943,738	29,236 Added 5.55%	556,363 $16.3 Million
Q2 2020 Aug 13, 2020	BUY	$24.48 - $36.56 $2.77 Million - $4.14 Million	113,356 Added 27.4%	527,127 $15.9 Million
Q1 2020 May 14, 2020	BUY	$18.5 - $36.9 $7.65 Million - $15.3 Million	413,771 New	413,771 $12.3 Million

Others Institutions Holding ARQT

# of Institutions

197

Shares Held

129M

Call Options Held

738K

Put Options Held

82K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $557M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Arcutis Biotherapeutics, Inc. Transaction History